Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine

Antiviral Research

Volumn 87, Issue 1, 2010, Pages 40-49

  Tajiri, Kazuto ^a   Ozawa, Tatsuhiko ^a   Jin, Aishun ^a   Tokimitsu, Yoshiharu ^a   Minemura, Masami ^a   Kishi, Hiroyuki ^a   Sugiyama, Toshiro ^a   Muraguchi, Atsushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cell microarray system; Hepatitis B surface antigen (HBsAg); Hepatitis B virus (HBV); Monoclonal antibody; Neutralization; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN STRUCTURE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; VACCINATION; VIRUS NEUTRALIZATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODY AFFINITY; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; EPITOPE MAPPING; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

HEPATITIS B VIRUS;

EID: 77953534416     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.04.006     Document Type: Article

References (36)

1. Abou-Jaoudé G., Sureau C. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J. Virol. 2005, 79:10460-10466.
2. Abou-Jaoudé G., Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J. Virol. 2007, 81:13057-13066.
3. Alter M.J. Epidemiology and prevention of hepatitis B. Semin. Liver Dis. 2003, 23:39-46.
4. Alves Vianna C.O., da Silva E., Mouta Júnior S., da Glória Teixeira Martins M., Batoreu N.M., Queiroz J.L., Gomes S.A., Magalhães de Andrade Góes A.C., Garcia Armoa G.R., Marques C.H., Baroni de Moraes M.T. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches. J. Immunol. Methods 2006, 313:38-47.
5. Beasley R.P., Hwang L.Y., Stevens C.E., Lin C.C., Hsieh F.J., Wang K.Y., Sun T.S., Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983, 3:135-141.
6. Borzì R.M., Dal Monte P., Honorati M.C., Facchini A. IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HBsAg. J. Immunol. Methods 1992, 146:17-23.
7. Carman W.F. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral Hepat. 1997, 4(Suppl. 1):11-20.
8. Cerec V., Glaise D., Garnier D., Morosan S., Turlin B., Drenou B., Gripon P., Kremsdorf D., Guguen-Guillouzo C., Corlu A. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 2007, 45:957-967.
9. Chayama K., Suzuki Y., Kobayashi M., Kobayashi M., Tsubota A., Hashimoto M., Miyano Y., Koike H., Kobayashi M., Koida I., Arase Y., Saitoh S., Murashima N., Ikeda K., Kumada H. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 1998, 27:1711-1716.
10. Chen Y.C., Delbrook K., Dealwis C., Mimms L., Mushahwar I.K., Mandecki W. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1997-2001.
11. Eren R., Ilan E., Nussbaum O., Lubin I., Terkieltaub D., Arazi Y., Ben-Moshe O., Kitchinzky A., Berr S., Gopher J., Zauberman A., Galun E., Shouval D., Daudi N., Eid A., Jurim O., Magnius L.O., Hammas B., Reisner Y., Dagan S. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology 2000, 32:588-596.
12. Galun E., Eren R., Safadi R., Ashour Y., Terrault N., Keeffe E.B., Matot E., Mizrachi S., Terkieltaub D., Zohar M., Lubin I., Gopher J., Shouval D., Dagan S. Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology 2002, 35:673-679.
13. Ganem D., Prince A.M. Hepatitis B virus infection - natural history and clinical consequences. N. Engl. J. Med. 2004, 350:1118-1129.
14. Glebe D., Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 2007, 13:22-38.
15. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., Guyomard C., Lucas J., Trepo C., Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15655-15660.
16. Huang C.F., Lin S.S., Ho Y.C., Chen F.L., Yang C.C. The immune response induced by hepatitis B virus principal antigens. Cell. Mol. Immunol. 2006, 3:97-106.
17. Jin A., Ozawa T., Tajiri K., Obata T., Kondo S., Kinoshita K., Kadowaki S., Takahashi K., Sugiyama T., Kishi H., Muraguchi A. A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat. Med. 2009, 9:1088-1092.
18. Kim S.H., Shin Y.W., Hong K.W., Chang K.H., Ryoo K.H., Paik S.H., Kim J.M., Brotman B., Pfähler W., Prince A.M. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees. Antiviral Res. 2008, 79:188-191.
19. Le Seyec J., Chouteau P., Cannie I., Guguen-Guillouzo C., Gripon P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 1998, 72:5573-5578.
20. Lucifora J., Durantel D., Testoni B., Hantz O., Levrero M., Zoulim F. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology 2010, 51:63-72.
21. Mangold C.M., Streeck R.E. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J. Virol. 1993, 67:4588-4597.
22. Maynard J.A., Maassen C.B., Leppla S.H., Brasky K., Patterson J.L., Iverson B.L., Georgiou G. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol. 2002, 20:597-601.
23. Neurath A.R., Kent S.B., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986, 46:429-436.
24. Ozawa T., Kishi H., Muraguchi A. Amplification and analysis of cDNA generated from a single cell by 5'-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells. Biotechniques 2006, 40:469-470. 472, 474.
25. Qiu X., Schroeder P., Bridon D. Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen. J. Immunol. 1996, 156:3350-3356.
26. Sa'adu A., Bidwell D., Locniskar M., Howard C., McAdam K.P., Voller A. Epitope mapping of HBsAg using a panel of human anti-HBs antibodies. J. Virol. Methods 1991, 35:199-206.
27. Sawada H., Iwasa S., Nishimura O., Kitano K. Efficient production of anti-(hepatitis B virus) antibodies and their neutralizing activity in chimpanzees. Appl. Microbiol. Biotechnol. 1995, 43:445-451.
28. Seeger C., Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000, 64:51-68.
29. Shin Y.W., Ryoo K.H., Hong K.W., Chang K.H., Choi J.S., So M., Kim P.K., Park J.Y., Bong K.T., Kim S.H. Human monoclonal antibody against hepatitis B virus surface antigen (HBsAg). Antiviral Res. 2007, 75:113-120.
30. Stirk H.J., Thornton J.M., Howard C.R. A topological model for hepatitis B surface antigen. Intervirology 1992, 33:148-158.
31. Tajiri K., Kishi H., Tokimitsu Y., Kondo S., Ozawa T., Kinoshita K., Jin A., Kadowaki S., Sugiyama T., Muraguchi A. Cell-microarray analysis of antigen-specific B-cells: single cell analysis of antigen receptor expression and specificity. Cytometry A 2007, 71:961-967.
32. The EASL Jury EASL International Consensus Conference on Hepatitis B. J. Hepatol. 2003, 38:533-540.
33. Tokimitsu Y., Kishi H., Kondo S., Honda R., Tajiri K., Motoki K., Ozawa T., Kadowaki S., Obata T., Fujiki S., Tateno C., Takaishi H., Chayama K., Yoshizato K., Tamiya E., Sugiyama T., Muraguchi A. Single lymphocyte analysis with a microwell array chip. Cytometry A 2007, 71:1003-1010.
34. Vyas G.N., Rao K.R., Ibrahim A.B. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science 1972, 178:1300-1301.
35. Waters J.A., Brown S.E., Steward M.W., Howard C.R., Thomas H.C. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res. 1992, 22:1-12.
36. Wu H., Beuerlein G., Nie Y., Smith H., Lee B.A., Hensler M., Huse W.D., Watkins J.D. Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6037-6042.